CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 99 enrolled
Drug / intervention
Hydrochlorothiazide +11 moredrug
Likely dose
Hydrochlorothiazide 25 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00661895
NCT00661895Phase 4Completed

Black Education and Treatment of Hypertension (BEAT HTN)

Creighton University·interventional·Posted Apr 21, 2008·Updated Dec 4, 2012

In Brief

A Phase 4 clinical trial evaluating Hydrochlorothiazide, Lisinopril, and 10 other interventions for Hypertension. Completed, enrolled 99 participants across 1 site.

Detailed Summary

Clinical trials have yet to test the adequacy of HTN control in African Americans (AA) when both control and intervention groups are given free antihypertensive medications and are involved in usual versus intensive intervention strategies. Because of this, it has not yet been determined whether the method of prescribing antihypertensive medications according to JNC 7 guidelines is more, less, or equally as effective as prescribing antihypertensive medications and providing intensive behavioral and clinical interventions. Knowledge in this area of HTN treatment should better able medical and health practitioners to help their AA subjects control HTN. The BEAT Hypertension Clinic will evaluate this method of HTN control by proposing a program that will evaluate the difference in HTN control among subjects receiving usual care and free medications and subjects also receiving free medications, but additionally being treated in a clinic that operates in a more intensive manner in relationship to patient behavior modification, patient-clinician interactions, and physical and social environments. At the conclusion of the study, the BEAT Hypertension Clinic investigators will report findings and help to answer the question of whether medication alone or medication combined with intensive behavioral and clinical treatment is more effective in HTN control in the AA population.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypertension
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedApr 21, 2008
Enrollment StartAug 1, 2005
Primary CompletionAug 1, 2009
Study CompletionNov 1, 2009
TodayJul 2, 2026
Enrollment to primary: 4 yearsPosted 18.2 years ago

Interventions

Hydrochlorothiazidedrug

Hydrochlorothiazide 25 mg tablets

Lisinoprildrug

Lisinopril 5mg Tablet, 10 mg tablet, 20 mg tablet

Lisinopril and Hydrochlorothiazidedrug

L 10 mg and H 12.5 mg tablets, L 20 mg and H 12.5 mg tablets, L 20 mg and H 25 mg tablets

Nifedipine XLdrug

30 mg extended release tablets, 60 mg extended release tablets

Metoprolol tartratedrug

50 mg tablets \& 100 mg tablets

Atenololdrug

50 mg tablet

Valsartandrug

80 mg tablets \& 160 mg tablet

Doxazosindrug

4 mg tablets

Clonidinedrug

0.2 mg tablets

Hydralazinedrug

50 mg tablets

Metoprolol succinatedrug

50 mg tablet \& 100 mg tablet

Amlodipinedrug

5 mg tablets \& 10 mg tablets